Piramal Pharma has announced the availability of the transcript from its conference call discussing the unaudited financial results for the quarter and nine months ending December 31, 2025. The transcript is accessible on the company’s website. This follows the company’s earlier communication on January 16, 2026, regarding the financial results. The conference call took place on January 29, 2026.
Conference Call Transcript Available
Piramal Pharma has released the transcript of its conference call pertaining to the unaudited financial results for the quarter and nine months ended December 31, 2025. This transcript provides insights into the company’s performance and strategic discussions during the call. The company encourages investors and stakeholders to review the document for detailed information.
Accessing the Transcript
The transcript is readily available on Piramal Pharma’s official website. Interested parties can access the document at https://www.piramalpharma.com/financial-reports. This resource allows for a comprehensive understanding of the discussions and analyses presented during the conference call that was held on January 29, 2026.
Background
This announcement is a follow-up to Piramal Pharma’s previous communication on January 16, 2026, concerning the company’s financial performance. The release of the transcript ensures transparency and enables stakeholders to gain a deeper understanding of the financial results and management’s perspectives.
Source: BSE
